Clinical Outcome Associated With Beta‐Lactam Allergy Labels in Hospitalized Patients in Belgium
Despite altered antibiotic use, we observed no association of BLAL or PenAL with clinical outcome parameters, highlighting regional differences and limiting transferability of non-EU findings to guide EU delabeling protocols.
Authors
- Rik Schrijvers (ORCID: https://orcid.org/0000-0002-4261-6220)
- Peter Declercq (ORCID: https://orcid.org/0000-0002-6338-2355)
- Willy Peetermans (ORCID: https://orcid.org/0000-0002-6974-8493)
- Greet Van De Sijpe (ORCID: https://orcid.org/0000-0003-1475-6178)
- Liesbeth Gilissen (ORCID: https://orcid.org/0000-0003-0927-3104)
- Paul De Munter (ORCID: https://orcid.org/0000-0002-5944-3530)
- Ileana Maria Ghiordanescu
- Isabel Spriet (ORCID: https://orcid.org/0000-0001-6342-0676)
- Dries Wets
- Anca Mirela Chiriac
- Annouschka Laenen
Institutions
- Université de Tours (FR)
- Inserm (FR)
- Université de Montpellier (FR)
- Statistics Belgium (BE)
- Centre Hospitalier Universitaire de Tours (FR)
- Clinical Investigation Center Plurithematic Tours (FR)
- Hôpital Arnaud de Villeneuve (FR)
- KU Leuven (BE)
Publication Details
- Journal
- Clinical and Translational Allergy
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1002/clt2.70166
- Citations
- 1
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 32.57